{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 451553497
| IUPAC_name = 5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
| image = Eterobarb.png
<!--Clinical data-->
| tradename = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 27511-99-5
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 33925
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 432SI047GA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04077
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 31271

<!--Chemical data-->
| C=16 | H=20 | N=2 | O=5
| molecular_weight = 320.340 g/mol
| smiles = CCC1(C(=O)N(C(=O)N(C1=O)COC)COC)C2=CC=CC=C2
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C16H20N2O5/c1-4-16(12-8-6-5-7-9-12)13(19)17(10-22-2)15(21)18(11-23-3)14(16)20/h5-9H,4,10-11H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = DACOQFZGGLCXMA-UHFFFAOYSA-N
}}

'''Eterobarb''' ('''Antilon''') is a [[barbiturate]] derivative. It has mainly [[anticonvulsant]] action with less [[sedative]] effects than the closely related compound [[phenobarbital]]. It saw reasonable success in clinical trials, but is not in widespread medical use.<ref>{{cite journal | last1 = Gallagher | first1 = BB | last2 = Baumel | first2 = IP | last3 = Woodbury | first3 = SG | last4 = Dimicco | first4 = JA | title = Clinical evaluation of eterobarb, a new anticonvulsant drug | journal = Neurology | volume = 25 | issue = 5 | pages = 399–404 | year = 1975 | pmid = 1094318 | doi=10.1212/wnl.25.5.399}}</ref><ref>{{cite journal | last1 = Smith | first1 = DB | last2 = Goldstein | first2 = SG | last3 = Roomet | first3 = A | title = A comparison of the toxicity effects of the anticonvulsant eterobarb (antilon, DMMP) and phenobarbital in normal human volunteers | journal = Epilepsia | volume = 27 | issue = 2 | pages = 149–55 | year = 1986 | pmid = 3956454 | doi=10.1111/j.1528-1157.1986.tb03518.x}}</ref>

==Synthesis==
Eterobarb can be synthesized by reacting [[phenobarbital]] with [[chloromethyl methyl ether]] in presence of a base.<ref>{{cite journal | doi = 10.1021/jm00285a002 | title=Anticonvulsants. 1. Alkoxymethyl derivatives of barbiturates and diphenylhydantoin | journal=Journal of Medicinal Chemistry | date=1971 | volume=14 | issue=3 | pages=187–189 | first=Julius A. | last=Vida}}</ref>

[[File:Eterobarb synthesis.png|thumb|center|500px|Eterobarb synthesis]]{{clear-left}}

== References ==
{{Reflist}}

{{Sedatives}}
{{Anticonvulsants}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:Ethers]]
[[Category:GABAA receptor positive allosteric modulators]]


{{nervous-system-drug-stub}}